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Introduction:
Liver transplantation is the only effective treatment available to patients with end stage chronic liver failure. Liver transplantation is highly effective but is a major surgical procedure with a 1 year mortality rate of 14% (1). Reducing the postoperative mortality rate is a major goal in liver transplant surgery.
Anaemia is a common finding in surgical patients occurring in approximately 30.4% of patients undergoing non-cardiac surgery (2) . Pre-operative anaemia has been identified as an independent risk factor for post-operative morbidity and mortality in several surgical fields (2)(3)(4)(5). In the setting of cardiac surgery, a haemoglobin level of less than 12mg/dL has been shown to increase the risk of surgical mortality three fold and the incidence of significant post-operative morbidity five fold (6) . The mechanism linking anaemia with poor outcome is unknown. Reduced tissue oxygenation, increased haemodilution and increased incidence of transfusion have been implicated as possible mechanisms of a reduced physiological ability to cope with the stress of major surgery (6) .
Anaemia is common in patients with advanced chronic liver disease. 75% of patients undergoing treatment for hepatitis C virus are anaemic (7) . The pathology of anaemia in severe liver disease is diverse including acute and chronic blood loss into the GI tract, malnutrition, haemolysis and treatment of viral hepatitis (8) (9) . As the underlying pathophysiology of the liver disease is so variable in this group of patients, the underlying type of anaemia in patients with chronic liver disease may similarly vary from iron deficiency to Vitamin B12 and folate deficiency (8)(10) making correction of anaemia difficult. Correction of haemoglobin levels in patients with Hepatitis C can be achieved with Erethropoetin (7).
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With the current median waiting time between being listed for transplantation to undergoing transplantation being 4-5 months in the UK (11) , there is ample time to correct pre-operative anaemia prior to transplantation.
Although anaemia has been investigated as a predictor of the need for intra-operative transfusions in liver transplantation (12)(13), the significance of pre-operative anaemia to the early outcomes of liver transplant surgery has not been established and was the aim of this study M A N U S C R I P T
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Methods:
A prospectively collected liver transplant database was reviewed between the years of 1998 and 2012 to allow significant sample size and adequate follow up data. All donor types (DBD, DCD, split and domino grafts) were included in the analysis. Retransplantations were also included.
Haemoglobin levels were measured in peripheral venous blood (Sysmex XE-2100, Sysmex Corporation, Milton Keynes, UK) on the day of admission for liver transplant along with full biochemistry profiles including a Model for End-Stage Liver Disease (MELD) score.
Transplant procedure:
Grafts were identified and retrieved through NHS blood and transplant (NHSBT) by the designated regional teams within the UK National Organ Retrieval Service (NORS). All grafts were retrieved according to the national standards for organ retrieval from deceased donors (NHSBT) (14). Grafts were routinely perfused in situ with cold University of Wisconsin (UW) solution (Organ Recovery Systems, Chicago).
Both piggy-back and caval replacement techniques for liver transplantation were utilised. Veno-venous bypass was not routinely employed.
1 mg of methylprednisolone (Pharmacia) was given intravenously during the anhepatic phase. All patients were monitored via invasive central and venous blood pressures.
Post operative management:
Post-operatively all patients were managed in the intensive care unit.
Haemoglobin levels were maintained below 10g/L to reduce the risk of graft thrombosis.
Platelets and fresh frozen plasma were administered only if there was active bleeding associated with a coagulopathy or thrombocytopaenia. Patients were routinely started on subcutaneous thromboprophylaxis on the first post-operative day.
All patients underwent a Doppler ultrasound scan of the liver vessels on the first, third and fifth post-operative day and underwent routine daily bloods including liver function tests.
Patients were extubated on the first post-operative day unless there was a clinical need for ongoing respiratory support.
Standard immunosuppression therapy was commenced on day one post-operatively.
Pre-operative anaemia:
Haemogloblin levels were documented on the day of admission for liver transplant and patients were classified as anaemic according to the World Health Organisation (WHO) definition of male <13g/dL or female <12g/dL (15). The need for intraoperative Red Cell Concentrate (RCC) transfusion was determined by the anaesthetic team and was based on blood loss, systemic haemodynamics and haemoglobin level on routine arterial blood gas analysis. Clotting factor replacement was based on blood loss and near patient coagulation monitoring using Thromboelastography (TEG) readings.
Mortality:
Patient mortality was defined as death from any cause and was calculated at 30 days, 90 days and at 1 year post transplantation.
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Morbidity:
Post-operative morbidity included, graft loss within 3 months, the need for organ support (respiratory and renal), biliary complication (leak and stricture), hepatic artery thrombosis (HAT), portal vein thrombosis (PVT) and post-operative infective episodes (bacterial/fungal/viral). Infective complications were only included when a positive culture was documented.
Donor, transplant and recipient factors:
When regression models were performed, pre-operative haemoglobin was adjusted for the donor variable age, the transplant variables -length of cold ischaemic time and length of vascular anastomosis time and the recipient variables -age, gender and preoperative MELD score.
MELD score and its relationship with haemoglobin:
To further explore the relationship between pre-operative haemoglobin levels and MELD score, MELD was broken down into the individual components that are used to calculate it -serum creatinine, serum bilirubin and INR (16) . Data regarding recent dialysis in the last week was missing and as such the UNOS modification of altering creatinine accordingly was not used.
Statistical analysis:
Results were analysed on the Statistical Package for the Social Sciences (SPSS) version 21, IBM. Univariate comparisons between anaemic and non-anaemic groups were performed using chi-squared tests for dichotomous variables and independent M A N U S C R I P T A C C E P T E D Table 2 . The main indications for transplantation were hepatitis C virus (HCV) related cirrhosis (23%) and alcoholic liver disease (ALD) (18%). Other indications are given in Table 3 . 
Incidence of pre-operative anaemia:
When calculated according to WHO classification (15), 580 patients (73%) were anaemic on the day of admission for liver transplantation. Anaemia was prevalent across all indications for transplantation ranging from 44-100% (Table 2) (Table 4) .
Pre-operative anaemia and post transplant outcomes:
On univariate analysis, anaemia did not correlate with 30 day (p=0.305), 90 day (p=0.170), or 1 year mortality (p=0.162). As the majority (73%) of patients were classified as anaemic, haemoglobin was further explored as a continuous variable.
Patients who died within 30 days had a significantly lower median pre-operative haemoglobin levels than patients that survived [10.6(9.1-11.6)g/dL vs 11.2(9.6- The presence of pre-operative anaemia was associated with a increased incidence of blood transfusion (P<0.001) and median number of units transfused (5 vs 2, p<0.001), an increased stay in ITU (p=0.015) and an increased need for respiratory support (p=0.005) but was not associated with an increased risk of post-operative complication rates including graft loss at 3 months (Table 5) .
A binary logistic regression analysis was performed to analyse whether pre-operative haemoglobin levels were an independent risk factor for post-operative mortality when adjusted for other donor, transplant and recipient variables. Pre-operative haemoglobin levels correlated with increased 1 year mortality (p=0.046) but not with mortality at 30 days (p=0.277) or 90 days (p=0.124) ( Table 6 ).
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Pre-operative haemoglobin levels were inversely correlated with MELD scores (p<0.001). As the MELD score increased (Figure 1) , the pre-operative haemoglobin level was lower by 0.398g/dL/unit MELD score. When MELD scores were excluded from the regression analysis, pre-operative haemoglobin levels correlated significantly with mortality at all time points (p=0.028, p=0.010, p=0.001) ( Table 7) .
To explore which individual factors of the MELD score influenced haemoglobin levels, a linear regression analysis was performed including pre-operative INR, bilirubin and creatinine levels. Pre-operative creatinine levels (p<0.001), INR (p<0.001) and bilirubin levels (p=0.007) were each significantly correlated with preoperative haemoglobin levels. For every increase in pre-operative creatine levels, serum haemoglobin levels dropped by 0.298g/dL/micromol/L creatinine while for every increase in bilirubin levels, serum haemoglobin levels dropped by 0.311g/dL/micromol/L bilirubin and for every increase in INR, haemoglobin levels dropped by 0.345g/dL/unit INR.
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Discussion:
This study is the first to analyse the role of pre-operative anaemia as a risk factor for mortality and the development of post-operative complications in liver transplant surgery. It has shown that pre-operative anaemia, as defined by the WHO classification, is not an independent risk factor for early post-operative mortality or the development of post-operative complications in this large cohort of patients undergoing liver transplantation. Anaemic patients are significantly more likely to require a blood transfusion and spend longer in ITU.
The incidence of anaemia, according to the WHO definition (15), in patients undergoing liver transplantation was high at 73%. This is in keeping with other studies of anaemia in patients with end stage liver disease (7) . The aetiology of anaemia in chronic liver disease is diverse; folate and vitamin B12 deficiency, hypersplenism, haemodilution, bone marrow suppression caused by ethanol or viruses, autoimmune haemolysis, renal insufficiency and variceal bleeding may all contribute (17) . Anaemia is postulated to increase bleeding risk through reduced platelet activation and aggregation, and worsening the hyperdynamic circulation (18) .
Our analysis suggests the anaemia is secondary to the severity of the chronic liver disease. We recorded a strong correlation between pre-operative haemoglobin level and MELD score. MELD is multifactorial and is calculated based on a patient's INR, serum creatinine and bilirubin levels (16) . To help identify the association between pre-operative haemoglobin levels and MELD score an analysis of individual factors of the MELD score and haemoglobin values was performed. This identified that both hepatic and renal dysfunction were associated with reduced haemoglobin levels.
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These findings are important for two reasons. Anaemia is strongly associated with renal dysfunction (19) and can be successfully treated with erythropoietin (EPO) (19) (20) . A previous study investigating anaemia in patients under treatment for advanced Hepatitis C demonstrated that anaemic patients, with advanced liver disease, could be successfully treated with daily EPO injections (21) . During the period of a patient waiting for a liver transplant, underlying low haemoglobin values could be corrected reducing the need for intra-operative transfusions and potentially improving outcome.
The major limitation of this study is that, along with the majority of other studies on pre-operative anaemia, it does not identify the underlying mechanism of the increased risk of post-operative mortality but suggests it may be secondary to severity of liver disease. Although it may be possible to correct low haemoglobin levels preoperatively, if the mechanism of increased risk of post-operative mortality is secondary to more advanced liver disease, it will not lead to decreased mortality levels post-operatively.
Correction of pre-operative anaemia may reduce the need for blood transfusion in this group of patients and may lead to a reduced requirement for intensive care support which would represent a cost saving for the health service. A full economic costing of the effect of correcting pre-operative haemoglobin levels would therefore be M A N U S C R I P T • Anaemia is highly prevalent in patients undergoing liver transplant (73%)
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• Unlike in other major surgery, anaemia is not associated with an increased risk of mortality post liver transplant.
• Haemoglobin levels are inversely correlated with MELD scores.
• When MELD scores are removed from the analysis, low haemogloblin levels are associated with higher mortality suggesting that anaemia may reflect worse pre-operative burden of disease.
